NCT05732831 2026-04-06Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid TumorsTango Therapeutics, Inc.Phase 1/2 Recruiting225 enrolled
NCT04483778 2025-11-20B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young AdultsSeattle Children's HospitalPhase 1 Active not recruiting68 enrolled
NCT03611868 2025-08-07A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid TumorsAscentage Pharma Group Inc.Phase 1/2 Active not recruiting230 enrolled